Growth Inhibitor
In Ankleshwar, feisty MSMEs that survived the Chinese onslaught say that the fight against red tapism is harder
Krishna Gopalan - January 25, 2019
Bhavin Shah
Sameeksha Capital's founder is impressed by PSP Projects’ execution and capital efficiency
December 14, 2017
Nursing Back to Health
A strong product pipeline and receding US FDA threat could well turn the tide in favour of the beleaguered pharma players
Jash Kriplani - October 18, 2017
Sankaran Naren
How the price of uncertainty threw up a great bargain in the form of Cadila Healthcare and how his relative bet on NTPC didn’t work out
Khushboo Balani - September 19, 2017
Here For Good
Despite the excise tax exemptions ending in a couple of years, Baddi is still seen as a hospitable cluster
Himanshu Kakkar - February 07, 2017
One giant leap for Mankind
Mankind Pharma made it big in small towns, but can its magic help it conquer the bigger markets?
Himanshu Kakkar - January 21, 2016
Wind beneath his wings
India's most reticent billionaire is betting his money on the alternative energy space and here's why
Krishna Gopalan - May 05, 2015
Trigger happy
Zydus Cadila COO Ganesh Nayak on how skeet shooting helps him keep his eyes trained on business goals
Laveena Iyer - January 07, 2015
Waiting for the next big leap
Lasting tie-ups with international players, besides innovation, have kept this chlorinated PVC market leader going
Krishna Gopalan - June 12, 2015
On safer shores
Bharuch is booming on the back of great roads, ports and a powered-up electrical grid
Krishna Gopalan - July 02, 2015